Kevin Bitterman Insider Trading $AKRO Akero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin Bitterman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin Bitterman. Kevin Bitterman is Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Editas Medicine, Inc. ($EDIT) and Director in Akero Therapeutics, Inc. ($AKRO).
Kevin Bitterman in Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kevin Bitterman: Director
Holdings: 11,780 shares
Latest Transaction: Oct 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kevin Bitterman in Akero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, EDIT, GNCA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Sell | S | 28.93 | 13,000 | 376,090 | 11,780 | 24.8 K to 11.8 K (-52.46 %) |
| Jun 02 2020 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
| Nov 12 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | A | 19.97 | 26,000 | 519,220 | 26,000 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 722,737 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | P | 16.00 | 270,000 | 4,320,000 | 505,099 | 235.1 K to 505.1 K (+114.85 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | C | 0.00 | 235,099 | 0 | 235,099 | 0 to 235.1 K |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | C | 0.00 | 3,469,759 | 0 | 3,469,759 | 0 to 3.5 M |
Page: 1